FDA Approved: LEXISCAN — Supplemental Application (Astellas Pharma US, Inc.)

View source ↗

Summary

The FDA approved a supplemental application for LEXISCAN (regadenoson) submitted by Astellas Pharma US, Inc. This action represents an update to the drug's mark…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Lexiscan (regadenoson)

Snippet

SUPPL AP for LEXISCAN (REGADENOSON)